Ethosuximide
Product Images NDC 61748-025

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 61748-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ea863fbc C47d 4130 A9b7 10b53f1db0e5 01)

Chemical Structure (Ea863fbc C47d 4130 A9b7 10b53f1db0e5 01)
Chemical structure of Ethosuximide depicting a five-membered ring with amide and keto functional groups and two methyl substituents attached to the ring.*
FDA Label Image

Container Label- 250 mg (Ea863fbc C47d 4130 A9b7 10b53f1db0e5 03)

Container Label- 250 mg (Ea863fbc C47d 4130 A9b7 10b53f1db0e5 03)
Ethosuximide Capsules, USP 250 mg bottle label from Akorn. The label states it contains 100 capsules and includes pharmacist dispensing instructions. Storage instructions and manufacturer information are visible, along with the NDC 61748-025-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.